Skip to main content
Erschienen in: Acta Diabetologica 2/2009

01.06.2009 | Original Article

Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients

verfasst von: Chen-Chung Fu, Du-An Wu, Ji-hung Wang, Wen-Chin Yang, Chin-Hsiao Tseng

Erschienen in: Acta Diabetologica | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

To investigate the relationship of micro-albuminuria with C-reactive protein (CRP) and hyperuricemia in Chinese patients with type 2 diabetes. All patients with type 2 diabetes, 40 years old and over were recruited consecutively from diabetic clinics at a medical center. Serum lipid, creatinine, uric acid, CRP, HbA1C and urinary albumin concentration were measured. A total of 515 patients, aged 60.3 ± 10.7 years were recruited and the number (rate) of micro- and macro-albuminuria were 109 (21.2%) and 55 (10.7%). The prevalence of micro-albuminuria for the quartiles of CRP levels demonstrated a meaningful trend of increases between groups from 17.4, 21.1, 30.3, and 31.2% (P trend = 0.002). Besides, the median CRP concentrations was significantly higher in the patients with micro- and macro-albuminuria than those with non-albuminuria. Stepwise logistic regression analysis revealed that CRP was significantly associated with abnormal albuminuria (OR = 1.36, 95% CI = 1.12–1.64, P = 0.002). After excluding those subjects with angiotensin-converting enzyme inhibitors/angiotension II receptor blockers or/and statin usage, the observed relationship between serum CRP levels and albuminuria was still persistent (OR = 1.61, 95% CI = 1.24–2.08, P < 0.001). In addition, hyperuricemia were significantly associated with abnormal albuminuria in the patients without diuretics, uricosuric agents or alcohol usage. Both serum CRP levels and hyperuricemia were significantly related to the presence of albuminuria in patients with diabetes. In addition, Chinese type 2 diabetic patients with serum CRP levels in the lower range as other ethnic groups can lead to the development of micro-albuminuria.
Literatur
1.
Zurück zum Zitat Alzaid AA (1996) Microalbuminuria in patients with NIDDM: an overview. Diabetes Care 19:79–89PubMedCrossRef Alzaid AA (1996) Microalbuminuria in patients with NIDDM: an overview. Diabetes Care 19:79–89PubMedCrossRef
2.
Zurück zum Zitat Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356–360PubMed Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356–360PubMed
3.
Zurück zum Zitat Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ (1984) Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabetes Med 1:17–19 Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ (1984) Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabetes Med 1:17–19
4.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Cruickshanks KJ (1995) Ten-year incidence of gross proteinuria in people with diabetes. Diabetes 44:916–923PubMedCrossRef Klein R, Klein BE, Moss SE, Cruickshanks KJ (1995) Ten-year incidence of gross proteinuria in people with diabetes. Diabetes 44:916–923PubMedCrossRef
5.
Zurück zum Zitat Parving HH, Hommel E, Mathiesen E, Skøtt P, Edsberg B, Bahnsen M, Lauritzen M, Hougaard P, Lauritzen E (1988) Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 296:156–160CrossRef Parving HH, Hommel E, Mathiesen E, Skøtt P, Edsberg B, Bahnsen M, Lauritzen M, Hougaard P, Lauritzen E (1988) Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 296:156–160CrossRef
6.
Zurück zum Zitat Schmitz A, Christensen T, Moller A, Mogensen CE (1990) Kidney function and cardiovascular risk factors in non-insulin- dependent diabetics (NIDDM) with microalbuminuria. J Intern Med 228:347–352PubMedCrossRef Schmitz A, Christensen T, Moller A, Mogensen CE (1990) Kidney function and cardiovascular risk factors in non-insulin- dependent diabetics (NIDDM) with microalbuminuria. J Intern Med 228:347–352PubMedCrossRef
7.
Zurück zum Zitat Nielsen S, Schmitz A, Mogensen CE (1991) Rate of progression of nephropathy in normo- and micro-albuminuric type II diabetic patients. Diabetologia 34:144ACrossRef Nielsen S, Schmitz A, Mogensen CE (1991) Rate of progression of nephropathy in normo- and micro-albuminuric type II diabetic patients. Diabetologia 34:144ACrossRef
8.
Zurück zum Zitat Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G (2001) Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest 31:318–321PubMedCrossRef Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G (2001) Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest 31:318–321PubMedCrossRef
9.
Zurück zum Zitat Tseng CH (2005) Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int 68:796–801PubMedCrossRef Tseng CH (2005) Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int 68:796–801PubMedCrossRef
10.
Zurück zum Zitat Molnar M, Wittmann I, Nagy J (2000) Prevalence, course and risk factors of diabetic nephropathy in type-2 diabetes mellitus. Med Sci Monit 6:929–936PubMed Molnar M, Wittmann I, Nagy J (2000) Prevalence, course and risk factors of diabetic nephropathy in type-2 diabetes mellitus. Med Sci Monit 6:929–936PubMed
11.
Zurück zum Zitat Lee KU, Park JY, Kim SW, Lee MH, Kim GS, Park SK, Park JS (1995) Prevalence and associated features of albuminuria in Koreans with NIDDM. Diabetes Care 18:793–799PubMedCrossRef Lee KU, Park JY, Kim SW, Lee MH, Kim GS, Park SK, Park JS (1995) Prevalence and associated features of albuminuria in Koreans with NIDDM. Diabetes Care 18:793–799PubMedCrossRef
12.
Zurück zum Zitat Collins VR, Dowse GK, Plehwe WE, Imo TT, Toelupe PM, Taylor HR, Zimmet PZ (1995) High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa. Diabetes Care 18:1140–1149PubMedCrossRef Collins VR, Dowse GK, Plehwe WE, Imo TT, Toelupe PM, Taylor HR, Zimmet PZ (1995) High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa. Diabetes Care 18:1140–1149PubMedCrossRef
13.
Zurück zum Zitat Go RC, Desmond R, Roseman JM, Bell DS, Vanichanan C, Acton RT (2001) Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetes. Diabetes Care 24:1764–1769PubMedCrossRef Go RC, Desmond R, Roseman JM, Bell DS, Vanichanan C, Acton RT (2001) Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetes. Diabetes Care 24:1764–1769PubMedCrossRef
14.
Zurück zum Zitat Lu B, Wen J, Song XY, Dong XH, Yang YH, Zhang ZY, Zhao NQ, Ye HY, Mou B, Chen FL, Liu Y, Shen Y, Wang XC, Zhou LN, Li YM, Zhu XX, Hu RM (2007) High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract 75:184–192PubMedCrossRef Lu B, Wen J, Song XY, Dong XH, Yang YH, Zhang ZY, Zhao NQ, Ye HY, Mou B, Chen FL, Liu Y, Shen Y, Wang XC, Zhou LN, Li YM, Zhu XX, Hu RM (2007) High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract 75:184–192PubMedCrossRef
15.
Zurück zum Zitat Koenig W, Sund M, Frohlich M, Fischer HG, Löwel H, Döring A, Hutchinson WL, Pepys MB (1999) C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 99:237–242PubMed Koenig W, Sund M, Frohlich M, Fischer HG, Löwel H, Döring A, Hutchinson WL, Pepys MB (1999) C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 99:237–242PubMed
16.
Zurück zum Zitat Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 36:973–979CrossRef Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 36:973–979CrossRef
17.
Zurück zum Zitat Festa A, D’Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM (2000) Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 58:1703–1710PubMedCrossRef Festa A, D’Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM (2000) Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 58:1703–1710PubMedCrossRef
18.
Zurück zum Zitat Navarro JF, Mora C, Maca M, Garca J (2003) Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis 42:53–61PubMedCrossRef Navarro JF, Mora C, Maca M, Garca J (2003) Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis 42:53–61PubMedCrossRef
19.
Zurück zum Zitat Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51:1157–1165PubMedCrossRef Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51:1157–1165PubMedCrossRef
20.
Zurück zum Zitat Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD (2002) C-reactive protein and soluble vascular cell adhesion-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk. Arterioscler Thromb Vasc Biol 22:593–598PubMedCrossRef Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD (2002) C-reactive protein and soluble vascular cell adhesion-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk. Arterioscler Thromb Vasc Biol 22:593–598PubMedCrossRef
21.
Zurück zum Zitat Yeo CK, Hapizah MN, Khalid BA, Nazaimoon WM, Khalid Y (2002) New coronary risk factors: is there a difference between diabetic patients with microalbuminuria compared to those without microalbuminuria? Med J Malaysia 57:298–303PubMed Yeo CK, Hapizah MN, Khalid BA, Nazaimoon WM, Khalid Y (2002) New coronary risk factors: is there a difference between diabetic patients with microalbuminuria compared to those without microalbuminuria? Med J Malaysia 57:298–303PubMed
22.
Zurück zum Zitat Gomes MB, Nogueira VG (2004) Acute-phase proteins and microalbuminuria among patients with type 2 diabetes. Diabetes Res Clin Pract 66:31–39PubMedCrossRef Gomes MB, Nogueira VG (2004) Acute-phase proteins and microalbuminuria among patients with type 2 diabetes. Diabetes Res Clin Pract 66:31–39PubMedCrossRef
23.
Zurück zum Zitat Nankivell BJ (2001) Creatinine clearance and the assessment of renal function. Aust Prescr 24:15–17 Nankivell BJ (2001) Creatinine clearance and the assessment of renal function. Aust Prescr 24:15–17
24.
Zurück zum Zitat Mikkelsen W (1999) The epidemiology of hyperuricaemia and gout. In: Smyth C, Holers V (eds) Gout, hyperuricaemia, and other crystal-associated arthropathies. Marcel Dekker, New York, pp 107–119 Mikkelsen W (1999) The epidemiology of hyperuricaemia and gout. In: Smyth C, Holers V (eds) Gout, hyperuricaemia, and other crystal-associated arthropathies. Marcel Dekker, New York, pp 107–119
25.
Zurück zum Zitat Shionoiri H, Sugimoto K, Kosaka T, Kita E, Oda H, Ushikubo T, Goto T, Takasaki I, Yasuda G (1998) Long-term therapy with an ACE inhibitor, temocapril, reduces microalbuminuria in essential hypertension. Hypertens Res 21:81–87PubMedCrossRef Shionoiri H, Sugimoto K, Kosaka T, Kita E, Oda H, Ushikubo T, Goto T, Takasaki I, Yasuda G (1998) Long-term therapy with an ACE inhibitor, temocapril, reduces microalbuminuria in essential hypertension. Hypertens Res 21:81–87PubMedCrossRef
26.
Zurück zum Zitat Fogari R, Mugellini A, Zoppi A, Lazzari P, Destro M, Rinaldi A, Preti P (2005) Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria. Eur J Clin Pharmacol 61:483–490PubMedCrossRef Fogari R, Mugellini A, Zoppi A, Lazzari P, Destro M, Rinaldi A, Preti P (2005) Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria. Eur J Clin Pharmacol 61:483–490PubMedCrossRef
27.
Zurück zum Zitat Albert MA, Danielson E, Rifai N, Ridker PM, P R I N C E Investigators (2001) Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. J Am Med Assoc 286:64–70CrossRef Albert MA, Danielson E, Rifai N, Ridker PM, P R I N C E Investigators (2001) Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. J Am Med Assoc 286:64–70CrossRef
28.
Zurück zum Zitat Mora S, Ridker PM (2006) Justification for the use of statins in primary prevention: an intervention trial evaluating rosuvastatin (JUPITER)–can C-reactive protein be used to target statin therapy in primary prevention? Am J Cardiol 97:33A–41APubMedCrossRef Mora S, Ridker PM (2006) Justification for the use of statins in primary prevention: an intervention trial evaluating rosuvastatin (JUPITER)–can C-reactive protein be used to target statin therapy in primary prevention? Am J Cardiol 97:33A–41APubMedCrossRef
29.
Zurück zum Zitat Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165–2168PubMed Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165–2168PubMed
30.
Zurück zum Zitat Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, Dhillon B, Weisel RD, Li RK, Mickle DA, Stewart DJ (2002) A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106:913–919PubMedCrossRef Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, Dhillon B, Weisel RD, Li RK, Mickle DA, Stewart DJ (2002) A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106:913–919PubMedCrossRef
31.
Zurück zum Zitat Saraheimo M, Teppo AM, Forsblom C, Fagerudd J, Groop PH (2003) Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients. Diabetologia 46:1402–1407PubMedCrossRef Saraheimo M, Teppo AM, Forsblom C, Fagerudd J, Groop PH (2003) Diabetic nephropathy is associated with low-grade inflammation in type 1 diabetic patients. Diabetologia 46:1402–1407PubMedCrossRef
32.
Zurück zum Zitat Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D’Agostino RB Jr, Herrington DM (2006) Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J 152:593–598PubMedCrossRef Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D’Agostino RB Jr, Herrington DM (2006) Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J 152:593–598PubMedCrossRef
33.
Zurück zum Zitat Low AF, Seow SC, Yeoh KG, Lim YT, Tan HC, Yeo TC (2004) High-sensitivity C-reactive protein is predictive of medium-term cardiac outcome in high-risk Asian patients presenting with chest pain syndrome without myocardial infarction. Ann Acad Med Singapore 33:407–412PubMed Low AF, Seow SC, Yeoh KG, Lim YT, Tan HC, Yeo TC (2004) High-sensitivity C-reactive protein is predictive of medium-term cardiac outcome in high-risk Asian patients presenting with chest pain syndrome without myocardial infarction. Ann Acad Med Singapore 33:407–412PubMed
34.
Zurück zum Zitat Nakamura M, Onoda T, Itai K, Ohsawa M, Satou K, Sakai T, Segawa T, Sasaki J, Tonari Y, Hiramori K, Okayama A (2004) Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Intern Med 43:919–925PubMedCrossRef Nakamura M, Onoda T, Itai K, Ohsawa M, Satou K, Sakai T, Segawa T, Sasaki J, Tonari Y, Hiramori K, Okayama A (2004) Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Intern Med 43:919–925PubMedCrossRef
35.
Zurück zum Zitat No authors listed (1985). Prevalence of small vessel and large vessel disease in diabetic patients from 14 centers: The World Health Organization Multinational Study of Vascular Disease in Diabetics. Diabetes Drafting Group. Diabetologia, 28 (Suppl.): 615–640 No authors listed (1985). Prevalence of small vessel and large vessel disease in diabetic patients from 14 centers: The World Health Organization Multinational Study of Vascular Disease in Diabetics. Diabetes Drafting Group. Diabetologia, 28 (Suppl.): 615–640
36.
Zurück zum Zitat Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ (2002) Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38:1101–1106CrossRef Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ (2002) Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38:1101–1106CrossRef
37.
Zurück zum Zitat Kang DH, Finch J, Nakagawa T, Karumanchi SA, Kanellis J, Granger J, Johnson RJ (2004) Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. J Hypertens 22:229–235PubMedCrossRef Kang DH, Finch J, Nakagawa T, Karumanchi SA, Kanellis J, Granger J, Johnson RJ (2004) Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. J Hypertens 22:229–235PubMedCrossRef
38.
Zurück zum Zitat Netea MG, Kullberg BJ, Blok WL, Netea RT, van der Meer JW (1999) The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice. Blood 89:577–582 Netea MG, Kullberg BJ, Blok WL, Netea RT, van der Meer JW (1999) The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice. Blood 89:577–582
39.
Zurück zum Zitat Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ (2003) Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41:1287–1293PubMedCrossRef Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ (2003) Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41:1287–1293PubMedCrossRef
40.
Zurück zum Zitat Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy PF 2nd, Kullo IJ (2007). Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 20:83–89 Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy PF 2nd, Kullo IJ (2007). Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 20:83–89
Metadaten
Titel
Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients
verfasst von
Chen-Chung Fu
Du-An Wu
Ji-hung Wang
Wen-Chin Yang
Chin-Hsiao Tseng
Publikationsdatum
01.06.2009
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 2/2009
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-008-0069-0

Weitere Artikel der Ausgabe 2/2009

Acta Diabetologica 2/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.